AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇲🇼

CO-AMOXICLAV in Malawi

12 products registered with PMRA 0 active, 12 expired

Brand / ProductReg. No.HolderStatusExpires
BACTOCLAV_DS 112.5MG SUSPENSION
SUSPENSION
PMPB/PL106/81expired31 Mar 2025
ZANITIN_INJECTION 1.2G INJECTION
INJECTION
PMPB/PL503/52expired31 Mar 2025
ZANITAN_DUO_625 625MG TABLET
TABLET
PMPB/PL503/45expired31 Mar 2025
ZANITIN_DUO_1000 1000MG TABLET
TABLET
PMPB/PL503/50expired31 Mar 2025
ZANITIN_DUO_228.5 228.5MG POWDER FOR ORAL SUSPENSION
POWDER FOR ORAL SUSPENSION
PMPB/PL503/51expired31 Mar 2025
MOXICOR_C-125 156.25MG SUSPENSION
SUSPENSION
PMPB/PL252/48expired30 Jun 2019
CLAVUJECT_1.2G 1.2G INJECTION
INJECTION
PMPB/PL351/58expired30 Jun 2016
MOXICOR-C 625MG TABLET
TABLET
PMPB/PL252/49expired30 Jun 2015
CLAMOVID-625 625MG TABLET
TABLET
PMPB/PL178/2expired30 Jun 2011
CLAMOVID 156.25MG/5ML GRANULES FOR SUSPENSION
GRANULES FOR SUSPENSION
PMPB/PL178/1expired30 Jun 2011
NOROCLAV-M 625MG FILM COATEDTABLETS
FILM COATEDTABLETS
PMPB/PL355/15expired30 Jun 2010
KOACT-156.25 156.25MG ORAL SUSPENSION
ORAL SUSPENSION
PMPB/PL132/38expired30 Jun 2010

CO-AMOXICLAVPMRA Registration Details

PMRA (Malawi) has 12 registered products containing CO-AMOXICLAV, of which 0 are currently active. Data is sourced directly from the official PMRA drug register and refreshed daily.

Track CO-AMOXICLAV registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.